Dr. Andrew Churchyard made this presentation at the sixth World Congress on Huntington's Disease, Rio de Janeiro, Brazil, September 15, 2013. Dr. Churchyard is a movement disorders neurologist based at Monash Medical Centre, Calvary Healthcare Bethlehem and Cabrini Hospitals and an Adjunct Clinical Associate Professor at Monash University in Melbourne, Australia. He has a strong interest in Huntington’s disease and neurogenetics as a clinician and as a medical research scientist. Since 2004 he has run the HD clinic at Bethlehem Hospital and also participates in predictive testing at the Murdoch Institute. He treats about 300 or so people with HD and enjoys helping those with HD and their families. As a practicing clinician he is particularly interested in developing evidence-based models of care that ensure that all of those living with HD receive acceptable access to care that they need. He also collaborates in research with colleagues at Monash University into various aspects of HD and in particular the use of neuroimaging and cognitive dysfunction in early disease. He is interested in research that might lead to effective treatments for people with HD or at risk of HD. He is a foundation member of the Huntington’s Research Group of Victoria, the local HD research network, and is a Huntington's Study Group investigator. He was chairman of the local organizing committee of the Melbourne 2011 World Congress of Huntington’s Disease. He is a member of the European Huntington's Disease Network. He sits on the steering committee of Enroll-HD, the senior governance committee of this prospective natural history study of Huntington’s disease. He is the principal investigator of Enroll-HD at the Calvary Healthcare-Monash University Enroll-HD site and sits on the editorial board of the Journal of Huntington’s Disease.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…